Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A quicker, cheaper way to detect staph in the body

03.02.2014
Synthetic probe identifies staph bacteria without need for biopsies

Chances are you won't know you've got a staph infection until the test results come in, days after the symptoms first appear. But what if your physician could identify the infection much more quickly and without having to take a biopsy and ship it off for analysis?


University of Iowa researchers have created a noninvasive probe that can detect a common strain of staph bacteria in the body. The staph bacteria are located via a light-emitting molecule (green), which is released when a bacterial enzyme (in orange) slices and separates the probe (shown in blue), shown in the illustration above.

Credit: McNamara lab, University of Iowa

Researchers at the University of Iowa may have found a way. The team has created a noninvasive chemical probe that detects a common species of staph bacteria in the body. The probe ingeniously takes advantage of staph's propensity to slash and tear at DNA, activating a beacon of sorts that lets doctors know where the bacteria are wreaking havoc.

"We've come up with a new way to detect staph bacteria that takes less time than current diagnostic approaches," says James McNamara, assistant professor in internal medicine at the UI and the corresponding author of the paper published Feb. 2 in Nature Medicine. "It builds on technology that's been around a long time, but with an important twist that allows our probe to be more specific and to last longer."

... more about:
»DNA »Medicine »healthy cell »immune system

The UI-developed probe targets Staphylococcus aureus, a species of staph bacteria common in hospitals and found in the general public as well. The bacteria causes skin infections, can spread to the joints and bones and can be fatal, particularly to those with weakened immune systems.

"Every year in the U.S., half a million people become infected by S. aureus bacteria, and 20,000 of those who become infected die," adds Frank Hernandez, a post-doctoral researcher at the UI and first author on the paper. "We believe that we are significantly improving the actual methods for detecting bacteria with a simple approach, which we expect to be cheap, fast and reliable."

What makes staph especially troublesome is doctors don't know the bacteria are in the body until they get the biopsy results, which usually takes days. "They're flying blind, so to speak," McNamara says. "It's the state of medicine at this time."

The UI team created a synthetic probe with two unique features. On one end is a molecule that gives off light under certain conditions. On the other end is another molecule that blocks that light. In other words, the particle, as designed, cancels itself out, leaving itself undetectable inside the body.

This is important due to what staph bacteria will do to the particle. In tests, nucleases (or enzymes) produced by the staph bacteria cleave the particles, like a warrior wielding a sword. (Why it does this is unclear, but scientists believe it's a clever way for staph, which can't move by itself, to spread beyond the molasses-like environment created when DNA leaks from infected, dying cells.) In any event, when staph cleaves the probe, it separates the light-emitting molecule from the light-blocking molecule, which then drifts too far away to block light. And, so with the right equipment, doctors would be able to see the light-emitting molecules and know that staph are raging there.

Outfitting such particles is not altogether new, but McNamara and his colleagues produced a probe that lasts longer—by several hours longer for certain types.

"We designed a tracking system that specifically identifies bacterial body localization in less than one hour," says Hernandez, a Colombian who for years has been working on probes to detect harmful bacteria.

Just as important, the UI probe has been chemically modified so that it's shredded only by the staph bacteria's nuclease and not by a nuclease secreted by normal, healthy cells. The team further tested the probe in mice and human serum and report that it performed as expected.

"That's the central idea, the underlying concept of our approach," says McNamara, whose primary appointment is in the Carver College of Medicine. "If the probe gets cleaved by serum nucleases, then our probe would be lit up all over the bloodstream. But since it's split only by staph nucleases, then we can pinpoint where the staph bacteria are active."

The team, which applied in fall 2012 for a final U.S. patent for the probe, plans to refine the probe, so it can be detected deeper in the body and to test its performance with catheter infections, according to McNamara.

McNamara acknowledges previous research by Arthur Arnone, UI professor emeritus in biochemistry, who was the first to define the structure of the S. aureus nuclease.

Contributing authors from the UI include Michael Olson, Luiza Hernandez, David Meyerholz, Daniel Thedens, Alexander Horswill. Lingyan Huang, Kristy Powers, and Mark Behlke from Integrated DNA Technologies in Coralville, Iowa also contributed to the study.

The National Institutes of Health (grant numbers AI 083211 and R21 AI 101391) funded the research. Hernandez is supported through a fellowship from the American Heart Association.

Richard Lewis | EurekAlert!
Further information:
http://www.uiowa.edu

Further reports about: DNA Medicine healthy cell immune system

More articles from Life Sciences:

nachricht Nanoparticle Exposure Can Awaken Dormant Viruses in the Lungs
16.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Cholera bacteria infect more effectively with a simple twist of shape
13.01.2017 | Princeton University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>